Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage |
Project Objective![]() |
Details |
---|---|---|---|---|---|---|
UC Davis | ||||||
USC | ||||||
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Cancer, Bone Marrow Transplant and Viral Infection |
Adult Stem Cell | Donor cell therapy | CHLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Donor cell therapy | Celularity Inc |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, X-linked (X-SCID) | Adult Stem Cell | Antibody | Jasper Therapeutics, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | Immune-Onc Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Corneal Damage | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Parkinson's Disease | Vital Research Opportunity | Gene Therapy, cell free | Brain Neurotherapy Bio |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Bone or Cartilage Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia, Leukemia, Acute Myeloid (AML) |
Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
IPEX Syndrome | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Amyotrophic Lateral Sclerosis | Adult Stem Cell | Gene-modified, donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Immune Disease, Leukocyte Adhesion Deficiency |
Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Type 1 diabetes | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Solid Tumors | BioEclipse Therapeutics INC. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |||
Brain Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cystinosis, Kidney Failure |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Heart failure | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | Angiocrine |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer, Breast Cancer |
Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Leukemia |
Cancer Stem Cell | Antibody | UCSD |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | ExCellThera Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Type 1 diabetes | Embryonic Stem Cell | Donor cell therapy | ViaCyte |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Boston Children's Hospital |
![]() |
Clinical Trial, Phase 2 | |
Retinitis Pigmentosa | Therapeutic Approach | jCyte |
![]() |
Clinical Trial, Phase 2 | ||
Retinitis Pigmentosa | Other | Donor cell therapy | jCyte |
![]() |
Clinical Trial, Phase 2 | |
Immune Disease, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 2 | |
COVID-19 | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 2 |